NEW YORK (TheStreet) -- RATINGS CHANGES

Abercrombie & Fitch (ANF) - Get Report was upgraded at Piper Jaffray to overweight from neutral. $27 price target. Company is leveraged to growing denim demand, Piper Jaffray said.

AutoZone (AZO) - Get Report was upgraded at Bank of America/Merrill Lynch to buy from neutral. $865 price target. Company has multiple ways to boost organic growth, Bank of America/Merrill Lynch said.

Bristol-Myers (BMY) - Get Report was upgraded at Piper Jaffray to neutral from underweight. Valuation call, based on a $61 price target, Piper Jaffray said.

Caesarstone (CSTE) - Get Report was upgraded at Barclays to overweight from equal-weight. Valuation call, based on a $59 price target, Barclays said.

Chevron (CVX) - Get Report was upgraded at Bank of America/Merrill Lynch to neutral from underperform. $100 price target. Valuation call, as the stock is trading with the highest yield in a decade, Bank of America/Merrill Lynch said.

21st Century Fox (FOXA) - Get Report was downgraded at Needham to hold from buy. Estimates were also cut, as original content continues to cost more, Needham said.

Intuit (INTU) - Get Report was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: INTU Ratings Report.

Johnson Controls (JCI) - Get Report was initiated with a neutral rating at Credit Suisse. $49 price target. Stock is already factoring in substantial margin increases, Credit Suisse said. Neutral rating.

Micron Technology (MU) - Get Report was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: MU Ratings Report.

Nike (NKE) - Get Report was upgraded at Telsey Advisory to outperform from market perform. $122 price target. Company can continue strong momentum, despite, tough comparisons, Telsey Advisory.

Sarepta (SRPT) - Get Report was upgraded at Piper Jaffray to overweight from neutral. $48 price target. Expect the Food and Drug Administration to accept Eteplirsen new drug filing, Piper Jaffray sad.

This article was written by a staff member of TheStreet.